IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.
NCT01219348
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
NSCLC
Lung Cancer
Interventions
BIOLOGICAL:
IDO peptide vaccination
Sponsor
Inge Marie Svane